Zetomipzomib - CAS 1629677-75-3

KZR-616, a first-in-class inhibitor of the immunoproteasome, selectively targets the LMP7 (IC50: 39/57 nM=hLMP7/mLMP7) and LMP2 (IC50: 131/179 nM=hLMP7/mLMP7) subunits of the immunoproteasome. KZR-616 has the potential for the research of multiple autoimmune diseases[1][2].

Proteasome, Others

Proteases/Proteasome, Ubiquitination, Others

1629599

C30H42N4O8

586.68

C([C@H](CC=1CCCC1)NC([C@H]([C@H](O)C2=CC=C(OC)C=C2)NC([C@@H](NC(CN3CCOCC3)=O)C)=O)=O)(=O)[C@@]4(C)CO4

-20°C

Ice Packs

Small Compound